TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2011

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.

Gheath Alatrash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.